Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Phase I study of GRN1005 in recurrent malignant glioma.

Drappatz J, Brenner A, Wong ET, Eichler A, Schiff D, Groves MD, Mikkelsen T, Rosenfeld S, Sarantopoulos J, Meyers CA, Fielding RM, Elian K, Wang X, Lawrence B, Shing M, Kelsey S, Castaigne JP, Wen PY.

Clin Cancer Res. 2013 Mar 15;19(6):1567-76. doi: 10.1158/1078-0432.CCR-12-2481. Epub 2013 Jan 24.

2.

Safety, pharmacokinetics, and activity of GRN1005, a novel conjugate of angiopep-2, a peptide facilitating brain penetration, and paclitaxel, in patients with advanced solid tumors.

Kurzrock R, Gabrail N, Chandhasin C, Moulder S, Smith C, Brenner A, Sankhala K, Mita A, Elian K, Bouchard D, Sarantopoulos J.

Mol Cancer Ther. 2012 Feb;11(2):308-16. doi: 10.1158/1535-7163.MCT-11-0566. Epub 2011 Dec 27.

3.

The unique neuroradiology of complex I deficiency due to NDUFA12L defect.

Barghuti F, Elian K, Gomori JM, Shaag A, Edvardson S, Saada A, Elpeleg O.

Mol Genet Metab. 2008 May;94(1):78-82. doi: 10.1016/j.ymgme.2007.11.013. Epub 2008 Jan 3.

PMID:
18180188
4.

Adverse response of non-indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine.

Botros B, Omar A, Elian K, Mohamed G, Soliman A, Salib A, Salman D, Saad M, Earhart K.

J Med Virol. 2006 Jun;78(6):787-91.

PMID:
16628582
5.

Parenteral vitamin B12 therapy of hyperhomocysteinemia in end-stage renal disease.

Hoffer LJ, Elian KM.

Clin Invest Med. 2004 Feb;27(1):10-3.

PMID:
15061579
6.

Hydroxocobalamin reduces hyperhomocysteinemia in end-stage renal disease.

Elian KM, Hoffer LJ.

Metabolism. 2002 Jul;51(7):881-6.

PMID:
12077735
7.

Plasma reduced homocysteine concentrations are increased in end-stage renal disease.

Hoffer LJ, Robitaille L, Elian KM, Bank I, Hongsprabhas P, Mamer OA.

Kidney Int. 2001 Jan;59(1):372-7.

Supplemental Content

Support Center